Strenza
Product Images NDC 73614-731

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Strenza (NDC 73614-731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Brisk Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Leaflet (Leaflet Strenza 10 15 24)

Patient information text panel for STRENZA, a pack containing three ophthalmic medication bottles. It details the medications included: Moxifloxacin Ophthalmic Solution USP 0.5% (3ml), Ketorolac Tromethamine Ophthalmic Solution 0.5% (5ml), and Prednisolone Acetate Ophthalmic Suspension USP 1% (5ml). The panel includes storage instructions and warnings on contamination, contact lens use, and concurrent ocular therapy.*

FDA Label Image

Box (Strenza Pack 10 10 2024)

STRENZA ophthalmic product packaging label by Brisk Pharmaceuticals with NDC 73614-731-03. The label indicates prescription use only and for use in eyes only. Each pack contains Moxifloxacin Ophthalmic Solution USP 0.5% in a 3ml bottle, Ketorolac Tromethamine Ophthalmic Solution 0.5% in a 5ml bottle, and Prednisolone Acetate Ophthalmic Suspension USP 1% in a 5ml bottle. The design features purple and orange graphic elements alongside the product name and company logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.